CTKB
Cytek BioSciences Inc

314
Mkt Cap
$571.56M
Volume
313,457.00
52W High
$6.18
52W Low
$2.37
PE Ratio
-44.21
CTKB Fundamentals
Price
$4.42
Prev Close
$4.47
Open
$4.41
50D MA
$5.17
Beta
1.38
Avg. Volume
830,031.10
EPS (Annual)
-$0.0461
P/B
1.51
Rev/Employee
$309,341.05
$597.53
Loading...
Loading...
News
all
press releases
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Analysts
Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) has been given a consensus recommendation of "Hold" by the seven research firms that are covering the company, MarketBeat Ratings reports. Two...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Brown Capital Management LLC Has $17.20 Million Position in Cytek Biosciences, Inc. $CTKB
Brown Capital Management LLC trimmed its position in Cytek Biosciences, Inc. (NASDAQ:CTKB - Free Report) by 30.3% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·6d ago
News Placeholder
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.2% - Here's What Happened
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.2% - Here's Why...
MarketBeat·28d ago
News Placeholder
Cytek Biosciences Preliminary Q4 Revenue Up 8%
(RTTNews) - Cytek Biosciences (CTKB) announced preliminary revenue results for the fourth quarter and full year ended December 31, 2025. Cytek expects total revenue for the full year 2025 to be...
Nasdaq News: Markets·28d ago
News Placeholder
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of "Hold" from Analysts
Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) has received a consensus recommendation of "Hold" from the eight research firms that are currently covering the firm, Marketbeat reports. Two...
MarketBeat·29d ago
News Placeholder
Cytek Biosciences (NASDAQ:CTKB) Given New $5.00 Price Target at TD Cowen
TD Cowen lifted their price objective on shares of Cytek Biosciences from $4.00 to $5.00 and gave the company a "buy" rating in a research report on Thursday...
MarketBeat·1mo ago
News Placeholder
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Recommendation of "Hold" by Brokerages
Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) has earned a consensus rating of "Hold" from the seven research firms that are covering the stock, MarketBeat.com reports. Two investment...
MarketBeat·2mo ago
News Placeholder
Cytek Biosciences (NASDAQ:CTKB) Stock Price Up 7.2% - Here's What Happened
Cytek Biosciences (NASDAQ:CTKB) Trading 7.2% Higher - Time to Buy...
MarketBeat·3mo ago
News Placeholder
Cytek Biosciences (NASDAQ:CTKB) Sees Unusually-High Trading Volume - Time to Buy?
Cytek Biosciences (NASDAQ:CTKB) Sees Large Volume Increase - Here's Why...
MarketBeat·3mo ago
News Placeholder
Cytek Biosciences (NASDAQ:CTKB) Shares Gap Up - Time to Buy?
Cytek Biosciences (NASDAQ:CTKB) Shares Gap Up - Here's What Happened...
MarketBeat·3mo ago
<
1
2
...
>

Latest CTKB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.